Table 12.
Compound | Mode of Action | Hydrophobic | Polar | H-Bond | п-п stacking | Charged |
---|---|---|---|---|---|---|
Potent Irreversible EFGR receptor | Tyr455, Ala554, Val557, Tyr619, Pro620, Cys622 | Thr556, Ser682, Ser759 | Asp760, Asp760, Arg553, Arg553, Asp623, Asp623, Asp623 | Lys621, Arg553, Arg553 | Lys621, Arg553, Arg624, Arg555, Arg545, Asp452, Asp623, Asp760, Asp761 | |
DNA Topoisomerase inhibitor | Tyr455, Tyr619, Pro620, Cys622, Ala550 | Ser549 | Asp760, Asp760, Asp623, Lys621, Tyr619 | Lys621, Arg553, Arg553 | Lys798, Arg621, Arg624, Arg555, Arg553, Lys551, Asp623, Asp618, Asp761, Asp760 | |
Antimalarial, Anti-inflammatory | Tyr455, Cys622, Pro620, Tyr619, Trp617, Ala762 | Asp761, Trp617, Asp760, Lys621, Asp761 | Arg553, Lys621 | Lys551, Arg553, Arg555, Arg624, Lys621, Lys798, Asp623, Asp618, Asp761, Asp760 | ||
Antimalarial | Tyr455, Cys622, Pro620, Tyr619, Trp617, Ala762 | Ser759 | Asp760, Asp760, Asp761 | Lys621, Arg553, Arg553, Asp452 | Lys551, Arg553, Asp452, Arg624, Asp623, Lys621, Asp618, Asp760, Asp761, Lys798 | |
Antibiotic | Tyr455, Ala554, Cys622, Pro620, Tyr619, Trp617, Ala762, Trp800, Phe812, Cys814 | Thr556, Ser682, Ser814 | Asp452, Asp623, Asp761, Trp617 | Arg553, Arg553 | Arg553, Arg555, Arg624, Lys621, Lys798, Asp452, Asp623, Asp618, Asp761, Asp760, Glu811 | |
Anti-HIV inhibitor | Tyr619, Pro620, Cys622, Tyr455, | Asn691, Thr680, Ser682, Thr556 | Arg553, Asn691, Arg555 | Lys621, Arg553 | Asp618, Asp760, Asp623, Lys621, Arg624, Arg553, Arg555, | |
Antiviral activity against positive and negative sense RNA viruses for example: Ebola, Marburg, Yellow fever, Zika virus | Tyr619, Pro620, Cys622, Tyr455 | Thr556 | Asp623, Asp618, Tyr619 | Asp618, Asp760, Asp623, Asp452, Lys798, Lys621, Arg624, Arg553, Lys551 | ||
Antimalarial Drug Anti-arthritis |
Cys622, Pro620, Tyr619, Tro617, Trp800, Ala762, Phe812, Cys813 | Ser814 | Asp760, Asp761, Asp761, Asp761, Asp623 | Lys621 | Asp623, Lys621, Asp618, Asp760, Asp761, Glu811, Lys798 | |
Toll-like receptor 7 Agonist | Tyr619, Pro620, Cys622, Tyr455 | Asp623, Arg553, Arg555 | Lys621, Arg553 | Lys621, Asp623, Asp618, Lys798, Arg624, Asp760, Asp452 | ||
β2 adrenoceptors agonist, muscarinic receptor antagonist | Cys622, Pro620, Tyr619, Trp617, Tyr455, Ala554 | Ser759, Asn691, Thr556, Ser814 | Lys621, Asp618, Asp760, Ala554 | Lys621, Tyr455, Arg553 | Lys621, Arg624, Asp623, Asp618, Lys551, Arg553, Arg555, Asp760, Asp761 | |
Anti-HIV Protease Inhibitor | Tyr619, Trp617, Pro620, Cys622, Ala762, Ala688 | Ser682, Thr687, Asn691, Thr556, Ser759 | Asp760, Asp623, Arg553, Arg555, Thr556 | Asp618, Glu811, Lys621, Arg624, Asp623, Lys545, Asp684, Arg555, Arg553, Asp760, Asp761 | ||
Tyrosine Kinase inhibitor; Epidermal Growth Factor Receptor (EGFR) inhibitor | Chain A: Tyr455, Ala554, Ala448 | Chain A: Asn552, Ser451, Asn447, Gln444 Chain C: Gln34 |
Chain A: Ala554, Asp445 | Chain A: Arg553, Ala554 | Chain A: Lys621, Arg624, Lys551, Arg553, Asp623, Asp445 | |
Tyrosine Kinase inhibitor; Epidermal Growth Factor Receptor (EGFR) inhibitor | Pro620, Cys622, Val166, Tyr455, Ala688 | Ser759, Asn691, Thr680, Ser681, Ser682 | Asp623, Lys621 | Arg553 | Lys798, Glu167, Asp760, Asp623, Arg624, Lys621, Arg553, Lys551 | |
Antiviral Drug | Tyr619, Val166, Pro620, Cys622, Met626, Tyr455 | Ser759, Thr680, Asn691, Asn552 | Lys798, Lys621, Cys622 | Arg553, Lys621 | Asp618, Lys798, Lys621, Arg624, Asp623, Lys551, Arg553, Asp760 |